Echocardiography and inflammatory biomarkers for predicting mortality and major adverse cardiovascular events in type 1 diabetes
Echocardiography combined with inflammatory biomarkers synergistically identifies individuals with type 1 diabetes, without known cardiovascular disease, who are at high risk of mortality and MACE.
Authors
- Line Jee Hartmann Rasmussen (ORCID: https://orcid.org/0000-0001-6613-2469)
- Hashmat Sayed Zohori Bahrami
- ULRIK DIXEN
- Peter Rossing
- Jens Dahlgaard Hove
- Magnus T. Jensen
- Peter Godsk Jørgensen
- Jesper Eugen-Olsen
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Queen Mary University of London (GB)
- Duke University (US)
- Hvidovre Hospital (DK)
- Gentofte Hospital (DK)
- William Harvey Research Institute (GB)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1186/s12933-025-03071-2
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00